Search

Your search keyword '"De Ferrari GM"' showing total 538 results

Search Constraints

Start Over You searched for: Author "De Ferrari GM" Remove constraint Author: "De Ferrari GM"
538 results on '"De Ferrari GM"'

Search Results

1. Efficacy versus safety: the dilemma of using novel platelet inhibitors for the treatment of patients with ischemic stroke and coronary artery disease

2. Ablation index predicts outcomes of catheter ablation of focal atrial tachycardia: results of a multicenter study

6. Cardiac contractility modulation in heart failure with reduced ejection fraction: critical review of evidence and application perspectives [Modulazione della contrattilità cardiaca nello scompenso cardiaco a frazione di eiezione ridotta: revisione critica delle evidenze ed aspetti decisionali pratici]

7. Cardiac contractility modulation in heart failure with reduced ejection fraction: critical review of evidence and application perspectives [Modulazione della contrattilità cardiaca nello scompenso cardiaco a frazione di eiezione ridotta: revisione critica delle evidenze ed aspetti decisionali pratici]

8. Risk factors for primary ventricular fibrillation during a first myocardial infarction: Clinical findings from PREDESTINATION (PRimary vEntricular fibrillation and suDden dEath during firST myocardIal iNfArcTION).

10. Physical Inactivity Is a Risk Factor for Primary Ventricular Fibrillation.

11. Clinical efficacy and safety of achieving very low LDL-cholesterol concentrations with the PCSK9 inhibitor evolocumab: a prespecified secondary analysis of the FOURIER trial

12. Evolocumab and clinical outcomes in patients with cardiovascular disease

13. Ezetimibe added to statin therapy after acute coronary syndromes

14. Evolocumab and clinical outcomes in patients with cardiovascular disease

15. Response to Letters Regarding Article, 'clinical Management of Catecholaminergic Polymorphic Ventricular Tachycardia: The Role of Left Cardiac Sympathetic Denervation'

18. Proportion of patients needing an implantable cardioverter defibrillator on the basis of current guidelines: impact on healthcare resources in Italy and the USA. Data from the ALPHA study registry

19. Predictors of mortality and hospitalization for cardiac causes in patients with heart failure and nonischemic heart disease: a subanalysis of the ALPHA study

20. Gene symbol: SCN5A. Disease: Brugada syndrome in Novel human pathological mutations

21. Atrial fibrillation in heart failure patients: prevalence in daily practice and effect on the severity of symptoms. Data from the ALPHA study registry

22. Gene Symbol: KCNH2 Disease: Long QT syndrome

23. Gene symbol: SCN5A. Disease: Long QT syndrome in Novel human pathological mutations

24. Gene symbol: KCNQ1. Disease: Long QT syndrome

25. PREDESTINATION: PRimary vEntricular fibrillation and suDden dEath during a firST myocardIal iNfArcTION: Genetic basis

26. Torsades de pointes following acute myocardial infarction: Evidence for a deadly link with a common genetic variant.

27. Left cardiac sympathetic denervation for catecholaminergic polymorphic ventricular tachycardia

28. Gene symbol: SCN5A. Disease: Brugada syndrome in Novel human pathological mutations

29. Gene symbol: SCN5A. Disease: Brugada syndrome

30. Gene symbol: KCNH2. Disease: Long QT syndrome in Novel human pathological mutations

31. Gene symbol: SCN5A. Disease: Long QT syndrome in Novel human pathological mutations

32. KCNH2-K897T Is a Genetic Modifier of Latent Congenital Long-QT Syndrome

36. KCNH2-K897T is a genetic modifier of latent congenital long-QT syndrome.

41. Association of hypertriglyceridemia with all-cause mortality and atherosclerotic cardiovascular events in a low-risk italian population: The TG-REAL Retrospective Cohort Analysis

42. Unanswered questions for management of acute coronary syndrome: risk stratification of patients with minimal disease or normal findings on coronary angiography

43. Cardioneuroablation: a new treatment for vasovagal syncope.

44. Myocarditis and pericarditis during COVID-19 pandemic: a study of the Italian Society of Cardiology.

45. External Validation of COAPT Risk Score in Patients Who Underwent Transcatheter Edge-To-Edge Repair of Severe, Functional Mitral Regurgitation: A Multicenter, Observational Italian-Polish Study.

46. From thick walls to clear answers: approaches to diagnosing hypertrophic cardiomyopathy and its mimics.

47. The role of antiarrhythmic drugs and stellate ganglion block in the acute management of electrical storm.

48. Feasibility of coronary access after transcatheter aortic valve implantation (TAVI): a systematic review and metanalysis of observational studies.

49. Organ perfusion pressure predicts outcomes in cardiogenic shock patients.

50. Mechanisms and Prognosis of Intolerance to Angiotensin Receptor Neprilysin Inhibitors in Advanced Heart Failure: Insights from Vasodilator Challenge.

Catalog

Books, media, physical & digital resources